John Sharkey
Corporate Officer/Principal presso GEOVAX LABS, INC.
Patrimonio netto: 281 $ in data 30/04/2024
Profilo
John W.
Sharkey is the founder of Cogas Consulting LLC, which was founded in 2010.
Currently, he is the Vice President-Business Development at GeoVax Labs, Inc. He has previously worked as the Chief Executive Officer at Largent Health LLC, Director at Sunridge International, Inc., VP-Business Development & Alliance Management at Shionogi Pharma, Inc., and Head-Business Development at Iconic Therapeutics, Inc. Dr. Sharkey holds a doctorate degree from the State University of New York at Buffalo and an undergraduate degree from The State University of New York.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GEOVAX LABS, INC.
0.01% | 01/08/2023 | 191 ( 0.01% ) | 281 $ | 30/04/2024 |
Posizioni attive di John Sharkey
| Società | Posizione | Inizio |
|---|---|---|
| GEOVAX LABS, INC. | Corporate Officer/Principal | 13/06/2022 |
Precedenti posizioni note di John Sharkey
| Società | Posizione | Fine |
|---|---|---|
| Cogas Consulting LLC | Fondatore | - |
| Largent Health LLC | Amministratore Delegato | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - |
| SUNRIDGE INTERNATIONAL, INC. | Direttore/Membro del Consiglio | - |
Formazione di John Sharkey
| State University of New York at Buffalo | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SUNRIDGE INTERNATIONAL, INC. | Health Technology |
| GEOVAX LABS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
| Largent Health LLC | |
| Cogas Consulting LLC |
- Borsa valori
- Insiders
- John Sharkey
